Extending invitations to Patient and Family Advisory Councils across Canada. This has resulted in geographic diversity of patient attendees at annual CADTH symposia.
Sharing opportunities on patient–partner matching services, including the Patient Advisors Network, the Patient & Researcher Connection Site, and the Cochrane Consumer Network. This has resulted in participation of patients and caregivers with specific lived experience to support Scientific Advice.
Following groups, connecting with moderators, and connecting with individuals on social media, including Facebook and TikTok. This has resulted in the participation of patients and caregivers with specific lived experiences to support the Post–COVID-19 Condition Level Review and Scientific Advice.
Research and direct outreach to patient and community groups unfamiliar with CADTH. This resulted in diverse insights shared for the Considerations for the Use of COVID-19 Rapid Tests Environmental Scan.
Calls for input and feedback via Twitter and the CADTH Weekly Summary email, reaching more than 10,000 subscribers. This has resulted in 180 unique patient groups contributing to CADTH Reimbursement Reviews over the years.
Via advisors at James Lind Alliance Priority Setting Partnerships introducing patients and clinicians to CADTH. This resulted in caregiver partners attending the Pediatric Glioma Real-World Evidence multi-stakeholder meeting.
With members of our Patient and Community Advisory Committee. This has resulted in patient participation in the 2022–2025 Strategic Plan development and launch, Best Brain Exchange in Real-World Evidence, and in other advisory committees at CADTH.
Past speakers, poster presenters, abstract reviewers, and travel grant recipients at annual CADTH symposia. This has resulted in past attendees joining the Symposium Planning Committee, reviewing abstracts, and presenting in plenary and panel sessions the following year.
Reconnecting with groups who have contributed input or feedback to CADTH. This has resulted in participants taking part in Scientific Advice and Real-World Evidence projects who bring their own lived experience and insights from a broader patient community. It also resulted in a patient expert discussing their own and others’ experiences with the expert committee to produce Guidance on Autologous Hematopoietic Cell Transplant for Patients With Multiple Sclerosis.
Introduction by clinicians or other external experts participating in HTA. This resulted in participation of patients and caregivers with specific lived experiences to contribute to the Intraocular Lenses for Infants with Aphakia HTA.
We seek patient contributors who:
have a direct connection to the health condition or technologies of interest
bring a perspective that can add to the diversity of ideas being shared
are comfortable sharing their experiences and insights in a supportive setting.